IMS Health Archives -

Young woman taking vitamins ginseng pill

Articles/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis

Urgent need for clarity as government suspends pharmacy cut plans

Linda Banks beyond the pill, government, healthcare, IMS Health, NHS, patients, pharmacist, pharmacy, webinar 0 Comment

But reprieve may last only until plans have been reviewed.

Urgent need for clarity as government suspends pharmacy cut plans

https://pharmaphorum.com/views-and-analysis/urgent-need-clarity-government-suspends-pharmacy-cut-plans/

Oncology/ Partner content/ Partner Content/ Press releases

The new CDF – Navigating Cancer Drug Access in England

Adam Jeffery access, cancer, CDF, England, ICAS, IMS Health, pharma 0 Comment

On July 29th 2016, the new process in England for cancer drugs seeking license went live – changing

The new CDF – Navigating Cancer Drug Access in England

https://pharmaphorum.com/partner-content-oncology/new-cdf-navigating-cancer-drug-access-england/

Audio/ Debates/ Debates & Insight/ Market Access/ Webinars/ Webinars On demand

Brexit – What now for pharma?

Louise Bellamy Brexit, IMS Health, NHS, pharma 0 Comment

Join us for a one-hour live webinar entitled Brexit – What now for pharma?

Brexit – What now for pharma?

https://pharmaphorum.com/debates-insight-market-access/brexit-webinar/

Diabetes webinar holding slide_4 3 05.08.16

Audio/ Debates/ Debates/ Debates/ Debates & Insight/ Debates & Insight/ Debates & Insights/ Digital and Social Media/ Patients/ R&D/ Sales and Marketing/ Webinars/ Webinars in home page/ Webinars On demand

Available on demand: Measuring the cost of the right interventions in diabetes

Louise Bellamy healthcare, IMS Health, market access, patients, pharma, UK 0 Comment

Available on Demand: Measuring the cost of the right interventions in diabetes.

Available on demand: Measuring the cost of the right interventions in diabetes

https://pharmaphorum.com/debates-insight-patients/measuring-cost-right-interventions-diabetes/

Market access webinar Widescreen size NEW v6

Audio/ Cancer/ Debates/ Debates/ Debates & Insight/ Debates & Insight/ Market Access/ Oncology/ Webinars/ Webinars On demand

Available on demand: Cancer Treatment Access: Strategy, Approach, Outcomes

Louise Bellamy cancer, commercial, HEOR, IMS Health, market access, marketing, NHS, NICE, Oncology, pharma 0 Comment

Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.

Available on demand: Cancer Treatment Access: Strategy, Approach, Outcomes

https://pharmaphorum.com/debates-insight-oncology/cancer-treatment-access-strategy-approach-outcomes/

Partner content/ Partner Content/ Press releases/ Sales and Marketing/ Sales and Marketing

IMS Health and Reltio Form Alliance to Deploy Advanced Information Management Solutions for Life Sciences

IMS Health data, IMS Health, pharma, Reltio 0 Comment

Providing Customers the Best in Big Data Technologies, High-Performance Analytics and Healthcare Information Capabilities DANBURY, CT, and REDWOOD

IMS Health and Reltio Form Alliance to Deploy Advanced Information Management Solutions for Life Sciences

https://pharmaphorum.com/partner-content-sales-marketing/ims-health-reltio-form-alliance-deploy-advanced-information-management-solutions-life-sciences/

Holding slide IMS pharmacy webinar_updated v3

Audio/ Debates/ Debates/ Debates & Insight/ Debates & Insight/ Market Access/ Sales and Marketing/ Webinars/ Webinars On demand

21/07/2016

Available on demand: What will changes to England’s pharmacy funding mean?

Louise Bellamy healthcare, IMS Health, market access, NHS, pharmacy 0 Comment

New measures proposed by the Government will impact community pharmacies across the UK.

Available on demand: What will changes to England’s pharmacy funding mean?

https://pharmaphorum.com/debates-insight-market-access/upcoming-changes-englands-pharmacy-funding-mean/

Articles/ Views and analysis

Healthcare systems aren’t making the most of biosimilars: pharma needs to support them

Linda Banks biologics, biosimilars, Celltrion, drug development, IMS Health, Sandoz, Zarxio 0 Comment

Biosimilars could save European and US healthcare systems billions – but more needs to be done to maximise

Healthcare systems aren’t making the most of biosimilars: pharma needs to support them

https://pharmaphorum.com/views-and-analysis/healthcare-systems-aren-t-making-the-most-of-biosimilars-pharma-needs-to-support-them/

Articles/ Healthcare/ UK & Europe/ Views and analysis

Manchester’s devolution revolution: will pharma get a seat at the table?

Andrew McConaghie Ferring, greater manchester devolution, IMS Health, Manchester, NHS 0 Comment

Manchester will lead the way towards integrated care

Manchester’s devolution revolution: will pharma get a seat at the table?

https://pharmaphorum.com/articles/manchesters-devolution-revolution-will-pharma-get-a-seat-at-the-table/

Trending

IMS Health

Login